BriaCell Therapeutics Corp. (BCTXW)

CA — Healthcare Sector
Peers: OCEA  SABS  NUWE  PKBO  VINC  PETV  LIXT  SYRS  KTTA  CELU 

Automate Your Wheel Strategy on BCTXW

With Tiblio's Option Bot, you can configure your own wheel strategy including BCTXW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

About BriaCell Therapeutics Corp. (BCTXW)

  • IPO Date 2012-08-13
  • Website https://briacell.com
  • Industry Biotechnology
  • CEO William V. Williams
  • Employees 16
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.